Gamma-terpinene

Other Names

1,4-Cyclohexadiene, 1-methyl-4-(1-methylethyl)-1,4-Cyclohexadiene, 1-methyl-4-isopropyl-1,4-p-Menthadiene1-Isopropyl-4-methyl-1,4-cyclohexadiene1-Isopropyl-4-methyl-cyclohexa-1,4-diene1-Isopropyl-4-methylcyclohexa-1,4-diene1-Methyl-4-(1-methylethyl)-1,4-cyclohexadiene1-Methyl-4-isopropyl-1,4-cyclohexadiene1-Methyl-4-isopropylcyclohexadiene-1,41-methyl-4-propan-2-yl-cyclohexa-1,4-diene1-methyl-4-propan-2-ylcyclohexa-1,4-diene4-Isopropyl-1-methyl-1,4-cyclohexadiene4-Methyl-1-(1-methylethyl)-1,4-cyclohexadieneCrithmeneFEMA 3559gamma-Terpinene (natural)MosleneNSC 21448p-Mentha-1,4-dieneTerpineneTerpinene, γ-γ-Terpinenγ-Terpineneγ-Terpinolene

Synopsis

Gamma-Terpinene: A Comprehensive Reference

1. Identity, Chemistry, and Physical Properties

Gamma-terpinene (γ-terpinene; also written γ-TPN) is a naturally occurring monocyclic monoterpene hydrocarbon. It is one of three isomeric monoterpenes differing in the positions of their two double bonds — the others being alpha- and beta-terpinene — and in gamma-terpinene the double bonds are at the 1- and 4-positions of the p-menthane skeleton. Gamma-terpinene is a monoterpene composed of two units of isoprene, containing ten carbon and sixteen hydrogen atoms (C₁₀H₁₆).

Its systematic IUPAC name is 1-methyl-4-(propan-2-yl)cyclohexa-1,4-diene, and it is also known as p-mentha-1,4-diene and 1,4-cyclohexadiene, 1-methyl-4-(1-methylethyl)-. It has a role as an antioxidant, a plant metabolite, a volatile oil component, and a human xenobiotic metabolite. It is classified as both a monoterpene and a cyclohexadiene. The CAS Registry Number is 99-85-4, and its molecular weight is 136.23 g/mol. It appears as a colourless liquid and possesses a distinctive turpentine-like odour. Gamma-terpinene is an isomer of several other terpenes, including D-limonene, alpha-pinene, beta-pinene, and alpha-terpinene.

1.1 Common Synonyms and Nomenclature

γ-Terpinene
p-Mentha-1,4-diene
1-Methyl-4-(1-methylethyl)-1,4-cyclohexadiene
1,4-p-Menthadiene
FEMA No. 3559 (flavoring use)
CAS No. 99-85-4; PubChem CID 7461

1.2 Physical and Chemical Characteristics

Gamma-terpinene is quite lipid-soluble, with a calculated Log P value of +4.50, demonstrating good bioavailability and adequate pharmacokinetic profile characteristics. Terpenes such as gamma-terpinene tend to polymerize by oxidation and are very unstable in alkaline functional bases such as soap.

2. Natural Sources and Botanical Origins

Gamma-terpinene is a cyclohexane monoterpene isolated from plant essential oils, including tea tree (Melaleuca alternifolia), oregano (Origanum vulgare), rosemary (Rosmarinus officinalis L.), thyme (Thymus vulgaris), and eucalyptus (Eucalyptus sp.). It has been isolated from a variety of additional plant sources including citrus fruits, coriander, cumin, celery, grapes, cinnamon, cloves, ginger, and pepper.

Gamma-terpinene is a terpene with molecular weight 136.3 g/mol and is a major component of essential oils made from citrus fruits. It is present in relatively large quantities (around 20%) in Ajowan essential oil, a seed grown in southern India that is botanically close to caraway and cumin. In tea tree oil (Melaleuca alternifolia), gamma-terpinene has been reported at approximately 28% of total composition alongside terpinen-4-ol (48%), 1,8-cineole (15%), and alpha-terpinene (13%).

Oregano belongs to the Origanum genus and the Lamiaceae family; the principal constituents of oregano oil include carvacrol, thymol, p-cymene, or γ-terpinene depending on its chemotype. Within the genus Satureja, significant variability in gamma-terpinene content has been documented: in a study of essential oil composition across 13 samples of Satureja thymbra collected from different locations in Crete, gamma-terpinene concentrations varied from approximately 4.4% to 20%.

Gamma-terpinene has also been isolated from cannabis and hops, in addition to plant sources such as savories (Satureja) and thyme.

3. Production and Commercial Forms

Gamma-terpinene is produced commercially via extraction from natural sources and by chemical synthesis. Steam distillation is the most common method used to extract it from essential oils such as tea tree oil (Melaleuca alternifolia). It can also be extracted from various source oils by fractional distillation. Alternatively, gamma-terpinene can be produced by metabolically engineered microorganisms such as Escherichia coli via a fermentation process.

Due to its strong lemon odor, gamma-terpinene is widely used in food, flavors, soaps, cosmetics, pharmaceuticals, tobacco, confectionery, and perfume industries. It is assigned FEMA Number 3559, indicating it has been evaluated and approved as a food flavoring substance by the Flavor and Extract Manufacturers Association (FEMA). It is commercially available as a concentrated aromatic and flavor ingredient used in flavor and fragrance compounds according to legal and IFRA or FEMA GRAS/FDA guidelines.

4. Traditional and Historical Use

Gamma-terpinene was identified as a component of various essential oils, such as tea tree oil, oregano oil, and marjoram oil in the 18th century and used as a natural remedy to treat various ailments. However, because gamma-terpinene was not identified as a discrete chemical entity until the modern era, all pre-modern traditional uses are properly attributed to the parent plants and their essential oils rather than to the isolated compound.

In folk medicine, extracts containing gamma-terpinene were valued for their antimicrobial, antioxidant, and anti-inflammatory properties. Cumin and coriander oils, rich in gamma-terpinene, were used in ancient Ayurvedic and Middle Eastern remedies to treat digestive disturbances, respiratory issues, and infections.

The parent plant Melaleuca alternifolia (tea tree) is indigenous to Australia and its leaf oil has been used by Aboriginal Australians for skin wounds and infections for centuries. Thyme (Thymus vulgaris) has a documented history of medicinal use in European folk medicine as an antimicrobial and expectorant. Oregano (Origanum vulgare) has been employed in Mediterranean traditional medicine for gastrointestinal, respiratory, and infectious conditions. Some terpenes found in plants used in traditional medicine have been used for centuries and are supported by numerous in vitro, animal, and clinical trials showing anti-inflammatory and other biological activities. It is important to note that these historical uses were not attributed specifically to gamma-terpinene as an isolated molecule; the attribution of activity to gamma-terpinene specifically is a product of modern phytochemical analysis.

5. Chemical Identity Within the Terpene Framework

The terpinenes are a group of isomeric hydrocarbons classified as monoterpenes. They each have the same molecular formula and carbon framework but differ in the position of carbon-carbon double bonds. Gamma-terpinene and delta-terpinene (also known as terpinolene) have been isolated from a variety of plant sources.

A notable structural feature is that gamma-terpinene contains a nonconjugated diene system, as opposed to the conjugated diene in alpha-terpinene. The nonconjugated diene in gamma-terpinene benefits antioxidant capacity more than a conjugated diene, which helps explain the superior antioxidant effectiveness of gamma-terpinene relative to alpha-terpinene.

Gamma-terpinene is also a metabolic precursor in essential oil biosynthesis. In thyme-type essential oils, gamma-terpinene serves as one of the biogenetic precursors of carvacrol and p-cymene.

6. Key Active Mechanisms

6.1 Antioxidant Activity: The Hydroperoxyl Radical Mechanism

The antioxidant activity of gamma-terpinene operates through an unusual mechanism that is fundamentally different from that of classical antioxidants such as vitamin E. Gamma-terpinene (TH), a monoterpene hydrocarbon present in essential oils, retards the peroxidation of linoleic acid. The peroxidation of TH has been shown to yield p-cymene as the only organic product in a chain reaction in which the chain carrier is the hydroperoxyl radical (HOO•). The retardation of lipid peroxidation by gamma-terpinene is due to rapid chain termination via a very fast cross-reaction between HOO• and LOO• radicals — a mechanism completely different from the mechanism of antioxidant action of vitamin E.

When acting synergistically with other antioxidants, gamma-terpinene acts synergistically, regenerating chain-breaking antioxidants such as PMHC and CAPE from their radicals, via the formation of hydroperoxyl radicals. Although gamma-terpinene is inactive when used alone in certain oxidizing environments, it prolongs, in a concentration-dependent manner, the protective activity of alpha-tocopherol and related phenolic antioxidants. Experiments on commercial sunflower oil showed that gamma-terpinene was able to prolong the induction time due to endogenous tocopherols, demonstrating that this terpene is a promising natural antioxidant for food applications at high temperature.

Studies comparing the two terpinene isomers directly found that gamma-terpinene can trap approximately 1.2 radicals when protecting erythrocytes and linoleic acid, meaning the antioxidant effectiveness of gamma-terpinene is higher than that of alpha-terpinene.

6.2 Anti-Inflammatory Mechanisms

In a carrageenan-induced peritonitis model, gamma-terpinene treatment reduced neutrophil migration as well as the production of interleukin-1β and tumor necrosis factor-α when compared to non-treated animals; and in an acute lung injury protocol, gamma-terpinene diminished neutrophil migration into lung tissue independently of total protein extravasation in the lung. Treatment with gamma-terpinene also inhibited fluid extravasation in the acetic acid model of microvascular permeability.

In a cancer pain model, gamma-terpinene reduced the levels of IL-1β, TNF-α, and iNOS in the tumour, and c-Fos protein in the spinal cord.

6.3 Antinociceptive (Pain-Modulating) Mechanisms

Gamma-terpinene has structural similarity to antinociceptive monoterpenes such as limonene and alpha-phellandrene. Mechanistic studies have revealed that its pain-modulating effects involve multiple receptor systems. Molecular docking studies demonstrate favorable binding energies between gamma-terpinene and alpha-2 adrenergic, glutamatergic, opioid, and cholinergic receptors.

6.4 Antiplatelet Mechanisms

Gamma-terpinene proved to be quite lipid-soluble (Log P = +4.50), with a qualified profile of drug-likeness, good bioavailability, and adequate pharmacokinetics. It exhibited affinity mainly for the P2Y12 receptor (binding energy −6.450 ± 0.232 Kcal/mol). The P2Y12 receptor is an ADP receptor critically involved in platelet activation, and is the target of antiplatelet drugs such as clopidogrel.

6.5 Antimicrobial Mechanisms

Tea tree oil, a major natural source of gamma-terpinene, appears to disrupt the permeability barrier of microbial cell membrane structures, causing loss of chemiosmotic control. This membrane-disruptive mechanism is thought to be a key contributor to the antimicrobial activity of gamma-terpinene and related monoterpenes.

7. Scientific Evidence by Area of Use

Monoterpenes such as gamma-terpinene exhibit relevant pharmacological effects that make them promising alternatives for the treatment of several clinical conditions. A review of the literature was conducted to compile the potential pharmacological effects of gamma-terpinene from in vitro and in vivo studies. After applying eligibility criteria, 13 articles were included in one such systematic review, which reported eight pharmacological activities including antibacterial, antiprotozoal, antioxidant, cytotoxic/antitumor, antiplatelet, anti-inflammatory, antihyperalgesic, and nervous system effects. It is critical to note that no human clinical trials evaluating gamma-terpinene as an isolated supplement have been identified in peer-reviewed literature as of mid-2025. The evidence base is composed entirely of in vitro (cell culture), in vivo (animal), and in silico (computational) studies.

7.1 Anti-Inflammatory Activity

Evidence level: Preclinical (animal and cell models only)

The monoterpene gamma-terpinene is a natural compound present in essential oils of a wide variety of plants, including the Eucalyptus genus, which has been reported to possess anti-inflammatory activity. The key preclinical study, published in Planta Medica (2015), tested gamma-terpinene in multiple murine models of acute inflammation: in a carrageenan-induced peritonitis model, gamma-terpinene treatment reduced neutrophil migration as well as the production of interleukin-1β and tumor necrosis factor-α. These data demonstrate that, in different models of inflammation, treatment with gamma-terpinene alleviated inflammatory parameters such as edema and pro-inflammatory cytokine production, as well as cell migration into the inflamed site, confirming anti-inflammatory properties.

These findings are limited to animal models; no controlled human studies have been conducted.

7.2 Antioxidant Activity

Evidence level: Strong in vitro and biochemical evidence; no human clinical trials

The antioxidant mechanism of gamma-terpinene is well-characterized at the biochemical level. The peroxidation of gamma-terpinene has been shown to yield p-cymene as the only organic product in a chain reaction in which the chain carrier is the hydroperoxyl radical (HOO•). Its unusual synergistic antioxidant role has been demonstrated in food chemistry research: the synergic antioxidant activity of gamma-terpinene with alpha-tocopherol, its synthetic analogue PMHC, BHT, TBHQ, and catechol was studied by measuring oxygen uptake and hydroperoxide formation in stripped sunflower oil at 130°C. Although gamma-terpinene was inactive when used alone, it prolonged, in a concentration-dependent manner, the protecting activity of alpha-tocopherol and PMHC.

Gamma-terpinene showed in silico affinity to the enzymes catalase and glutathione reductase, and in vivo amplification of catalase activity in erythrocytes of gamma-terpinene-treated spontaneously hypertensive rats.

In essential oil blend studies, an essential oil characterized by γ-terpinene (39.23%) as the major constituent possessed strong antioxidant activity as measured by the DPPH free radical scavenging method, with an IC50 of 0.0967 mg/mL. However, in studies comparing individual isolated constituents, thymol exhibited two-fold greater antioxidant potency than carvacrol, whereas gamma-terpinene and p-cymene had no significant effect in that antiproliferative assay. This highlights the context-dependence of the antioxidant activity — gamma-terpinene's mechanism is primarily as a synergist/co-antioxidant rather than a direct radical scavenger in all assay formats.

7.3 Antimicrobial Activity (Antibacterial and Antifungal)

Evidence level: Preclinical in vitro only; no human clinical trials

In studies on Satureja thymbra essential oil, gamma-terpinene alongside thymol and carvacrol showed strong antimicrobial activity against both bacterial and fungal species. Regarding antifungal activity specifically, gamma-terpinene was tested against Candida albicans: the essential oil showed antifungal activity against four C. albicans strains; the most sensitive strain was C. albicans 14065 with an MFC of 2.0 mg/mL and MIC₅₀ of 0.125 mg/mL with alpha-pinene, while gamma-terpinene had an MFC of 16.0 mg/mL.

In the context of vaginal microbiome pathogens, research published in Scientific Reports (2022) examined the antimicrobial activity of thyme essential oil components against Gardnerella species: the authors assessed potential synergism between some of the essential oil's main components to develop a future topical application against Gardnerella biofilms. The composition of the tested oils was mainly carvacrol (73.9–80.0%) with its biogenetic precursors gamma-terpinene (3.4–7.4%) and p-cymene (4.1–4.9%). Gamma-terpinene's individual contribution to antimicrobial activity in many blend studies is difficult to isolate, as it typically co-occurs with the more potent constituents carvacrol and thymol.

In a study on tangerine (Citrus deliciosa) essential oil, in which gamma-terpinene represented 13.8% of composition, the essential oil showed antifungal action against all tested yeasts, with promising action against Cryptococcus neoformans, Cryptococcus gattii, and Trichosporon asahii, and was also able to inhibit biofilm production.

7.4 Antinociceptive (Analgesic) Activity

Evidence level: Animal models only; no human clinical trials

A 2015 study published in Evidence-Based Complementary and Alternative Medicine examined the antinociceptive mechanisms of gamma-terpinene in rodent models: gamma-terpinene at oral doses of 1.562 to 50 mg/kg showed an antinociceptive effect in the formalin, capsaicin, and glutamate tests. It has antinociceptive action when administered by other routes in the glutamate test. The open field and rota-rod tests confirmed that gamma-terpinene did not show muscle relaxant activity or central depressant effect.

Research on neuropathic pain extended these findings: daily treatment for six days with gamma-terpinene (50 mg/kg, p.o.) and gamma-terpinene complexed in beta-cyclodextrin (50 mg/kg, p.o.) significantly reduced (p < 0.001) the mechanical hyperalgesia induced by the administration of 2×10⁶ sarcoma cells 180 around the sciatic nerve in a murine cancer pain model. The grip and rota-rod techniques demonstrated no interference on muscle strength and motor coordination, suggesting the compound does not have central nervous system depressant effects at the doses used.

An earlier study using beta-cyclodextrin complexation found that beta-cyclodextrin improved the physicochemical properties and prolonged the anti-hyperalgesic effect of gamma-terpinene. Calcium channel blockade has been proposed as a mechanism: the effects of gamma-terpinene on calcium channels were studied by patch-clamp and molecular docking, indicating that calcium channel modulation may contribute to its analgesic effects.

7.5 Antiplatelet and Cardiovascular Activity

Evidence level: In vitro and animal (non-clinical) only; no human clinical trials

Terpenes are widely studied molecules pharmacologically active on the cardiovascular system, hemostasis, and antioxidant actions. A 2024 study published in Naunyn-Schmiedeberg's Archives of Pharmacology evaluated gamma-terpinene's antiplatelet potential: it exhibited affinity mainly for the P2Y12 receptor (binding energy −6.450 ± 0.232 Kcal/mol), and its presence in SVEC 4-10 endothelial cells was able to reduce platelet aggregation by 51.57 and 44.20% at concentrations of 50 and 100 µM, respectively. This study concluded that gamma-terpinene has good affinity with purinergic receptors and an effect on the reversal of platelet aggregation and oxidative stress, being promising and safe for therapeutic targets and subsequent studies on the control of thromboembolic diseases. All results reported are non-clinical (in vitro and animal model); the clinical significance in humans is not established.

7.6 Cytotoxic and Anticancer Activity

Evidence level: In vitro and animal models only; no human clinical trials

A 2025 study evaluated the toxicogenetic and antioxidant profile of gamma-terpinene: the compound was moderately toxic on Artemia salina nauplii (LC50 = 136.1 µM) and reduced proliferation of melanoma B16-F10 tumor cells (IC50 = 38.19 µM), without affecting viability of normal RAW 264.7 macrophages and mammalian erythrocytes' membrane.

A 2024 study published in Heliyon investigated gamma-terpinene's effects on the A-2058 melanoma cell line: the purpose was to investigate the potential anticarcinogenic effects of alpha-pinene, gamma-terpinene, and p-cymene on melanoma cells, and to explore synergistic activities of these phytochemicals with dacarbazine, a chemotherapy drug. The study used AO/EB staining for apoptosis detection, cell cycle analysis by flow cytometry, and determination of mRNA expression levels of apoptosis-regulatory genes including p53, Bax, NF-kB, Bcl-2, Bcl-xl, and caspase-3. These three phytochemicals significantly increased caspase-3 activity in A-2058 cells compared to control and dacarbazine groups. In particular, gamma-terpinene triggered caspase-3 activity very strongly in melanoma cells. These are all cell-culture and animal-tumor model findings; no clinical anticancer evidence exists for isolated gamma-terpinene.

At concentrations of 12.5, 25 and 50 µM, gamma-terpinene intensively reduced the mitotic index of dividing Allium cepa meristematic cells in a non-concentration-dependent way and caused increases in interphase and reduction in prophase cells (p < 0.05). This finding raises some genotoxic concerns worthy of further investigation (see Safety section below).

7.7 Antiparasitic Activity

Evidence level: In vitro and in vivo animal studies only

Gamma-terpinene has been investigated for its activity against the protozoan parasite Trypanosoma evansi: this study aimed to evaluate the susceptibility in vitro and in vivo of Trypanosoma evansi to terpinen-4-ol, gamma-terpinene, and alpha-terpinene, the three main compounds of tea tree oil. In vitro, a trypanocidal effect of all three compounds was observed when used alone or in association at 0.5, 1, and 2% concentrations.

In the context of leishmaniasis, a 2022 study published in Experimental Parasitology examined gamma-terpinene's antileishmanial activity: gamma-terpinene demonstrated notable dose-dependent antileishmanial effects towards promastigotes and amastigotes of Leishmania major. The IC50 values for gamma-terpinene against L. major promastigotes and amastigotes were 46.76 mM and 25.89 mM, respectively. The mechanism of action appears to involve an immunomodulatory role towards upregulation of iNOS and JAK-1, while downregulating IL-10 and TGF-β. Moreover, gamma-terpinene has antioxidative potential and exerts its action through activating macrophages to kill the organism. Further in vivo and clinical studies are essential to explore its effect.

7.8 Nervous System Effects

Evidence level: Animal and observational correlation data; no clinical trials

A survey study found that gamma-terpinene, among other terpenes, correlated with decreased perceived anxiolytic activity in patients with anxiety using cannabis strains. However, it is unclear to what extent these terpenes contributed to the activity, as they may be correlated with other influencing factors such as cannabinoid content, additional phytocannabinoids, or expectation bias.

7.9 Insecticidal Activity

Monoterpene terpinene has been shown to present significant activity against the stored grain weevil Sitophilus zeamais in fumigant assay conditions. Chromatographic findings in tea tree oil (M. alternifolia) confirmed that terpinen-4-ol, gamma-terpinene, and alpha-terpinene are among the most abundant compounds responsible for its insecticidal activity.

8. Body Systems and Health Areas of Association

Immune and inflammatory system: Reduction of pro-inflammatory cytokines (TNF-α, IL-1β), inhibition of neutrophil migration; preclinical evidence only.
Cardiovascular/hemostatic system: Antiplatelet activity via P2Y12 receptor affinity; antioxidant protection of lipids against peroxidation; non-clinical evidence only.
Nervous system / pain pathways: Antinociception via opioid, cholinergic, glutamatergic, and adrenergic pathways; calcium channel modulation; animal models only.
Antimicrobial (bacterial, fungal, parasitic): Activity against bacteria, Candida spp., Leishmania spp., Trypanosoma spp.; membrane disruption mechanism; in vitro and limited animal evidence.
Oncology/cellular proliferation: Pro-apoptotic activity (caspase-3 activation, cell cycle arrest) in melanoma cell lines and other tumor models; in vitro and animal data only.
Food/lipid preservation: Synergistic antioxidant with tocopherols; well-characterized biochemical mechanism with food science application data.

9. Dosage Forms and Reported Dosages

Gamma-terpinene is not currently approved as a standalone pharmaceutical or dietary supplement with established clinical dosages. The following dosages are those used in preclinical research, reported here strictly as described in cited sources:

Antinociception (oral, rodent): Gamma-terpinene at oral doses of 1.562 to 50 mg/kg demonstrated antinociceptive effects in formalin, capsaicin, and glutamate tests in mice.
Acute toxicity threshold (oral, rodent): Animals did not present any signs of acute toxicity at 2 g/kg administered orally.
Cancer pain / neuropathic pain model (oral, rodent): Daily treatment for six days with gamma-terpinene at 50 mg/kg (p.o.) or gamma-terpinene/beta-cyclodextrin complex at 50 mg/kg (p.o.) significantly reduced mechanical hyperalgesia (p < 0.001) in a sarcoma tumor model.
Antiplatelet study (gavage, spontaneously hypertensive rats): Animals were pre-treated by gavage with gamma-terpinene for 7 days and divided into four groups: negative control, 25, 50, and 100 mg/kg.
Antiplatelet (in vitro): Gamma-terpinene exhibited moderate cytotoxicity for L-929 cells (CC50 = 333.3 µM) and SVEC 4-10 cells (CC50 = 366.7 µM); it reduced platelet aggregation by 51.57 and 44.20% at lower concentrations (50 and 100 µM, respectively).
Antitumor (melanoma B16-F10, in vitro): Gamma-terpinene reduced proliferation of melanoma B16-F10 tumor cells at an IC50 value of 38.19 µM.
Antileishmanial (in vitro): IC50 values against L. major promastigotes and amastigotes were 46.76 mM and 25.89 mM, respectively.
High-temperature oil antioxidant (food application): In sunflower oil oxidation experiments at 130°C, gamma-terpinene was evaluated at 1% (w/w) in combination with alpha-tocopherol at 0.1% (w/w).

Dosage forms in which gamma-terpinene occurs commercially include: isolated terpene fractions (typically 95–98% purity by GC), constituent of certified essential oils (tea tree, thyme, oregano, citrus), food flavoring preparations (where it holds FEMA GRAS status), and cosmetic/fragrance formulations.

10. Safety Considerations

10.1 Regulatory Status

Gamma-terpinene holds FEMA Number 3559, indicating assessment and acceptance as a GRAS (Generally Recognized as Safe) flavoring substance by the Flavor and Extract Manufacturers Association, permitting its use as a flavor ingredient in food according to FDA and FEMA guidelines.

10.2 Acute Toxicity

In rodent studies, animals did not present any signs of acute toxicity at a dose of 2 g/kg administered orally. In separate studies evaluating moderate toxicity: the compound was moderately toxic to Artemia salina nauplii with an LC50 of 136.1 µM, while it did not affect viability of normal RAW 264.7 macrophages and mammalian erythrocytes' membrane at cytotoxic concentrations for tumor cells.

10.3 Genotoxicity Concerns

A 2025 preclinical study raised concerns about genotoxic potential at higher doses: gamma-terpinene at concentrations of 12.5, 25, and 50 µM intensively reduced the mitotic index of dividing Allium cepa meristematic cells in a non-concentration-dependent way and caused increases in interphase and reduction in prophase cells (p < 0.05). An increase in binucleated cells was observed at the highest dose (100 mg/kg/day) only. As a natural molecule, gamma-terpinene is not free of damaging effects, and further investigations are needed to ensure limiting doses and regulation aspects.

10.4 Oxidation and Allergenicity

Gamma-terpinene can form allergens by auto-oxidation, according to published evidence. This is a property common to many unsaturated terpene hydrocarbons, including limonene and linalool, and is particularly relevant to dermal exposure in cosmetic and fragrance applications. Terpenes tend to polymerize by oxidation, meaning that degraded or improperly stored preparations may contain oxidation products with potentially greater sensitizing potential than the fresh compound.

10.5 High-Dose Exposure Risks

While ingestion or exposure to large amounts of terpinenes can lead to severe health consequences such as kidney pain, blisters, inflammation, and tachycardia, these are only observed in cases where significant amounts of essential oils have been consumed or inhaled. Exposure to the quantities found in household products, foods, or cannabis is unlikely to cause any issues.

10.6 Pharmacokinetic Considerations

Gamma-terpinene has high lipophilicity and limited pharmacokinetics. Research on improving its drug-like properties has explored encapsulation: complexation in beta-cyclodextrin improved the physicochemical properties and prolonged the anti-hyperalgesic effect of gamma-terpinene, suggesting that raw gamma-terpinene may have limited duration of action due to rapid volatilization or metabolism. Pharmacokinetic modeling has qualified its profile as having good bioavailability.

10.7 Absence of Human Interaction Data

No peer-reviewed human studies or clinical pharmacokinetic investigations for isolated gamma-terpinene as a dietary supplement have been identified. Its potential for interaction with antiplatelet drugs (given its demonstrated P2Y12 receptor affinity in vitro) and with metabolizing enzymes (given its lipophilicity and xenobiotic metabolite classification) are mechanistically plausible areas of concern that have not been investigated in clinical settings.

11. Current State of Evidence: Summary Assessment

Gamma-terpinene exhibits relevant pharmacological effects that make it a promising alternative for the treatment of several clinical conditions. However, the totality of evidence supporting any specific health application of isolated gamma-terpinene as a dietary supplement remains at the preclinical stage. All identified studies are either in vitro (cell-based), in vivo animal models, or in silico (computational), with the 2025 systematic review identifying only 13 qualifying publications in the entire literature to that date. Further studies need to be conducted before conclusions about efficacy or safety in humans can be drawn. The compound's role as a food flavoring ingredient (FEMA GRAS) at low concentrations in food products is better established from a regulatory standpoint than any therapeutic claim.

References

Health Conditions

Health conditions that Gamma-terpinene may help support.

No conditions available.

Body Systems

Body systems that Gamma-terpinene may help support.

No body systems available.